The Caribbean Public Health Agency (CARPHA) has expanded its laboratory testing capacity with the official opening of its Antimicrobial Resistance (AMR) Regional Reference Referral Laboratory in Saint Lucia. The ceremony, brought together regional health officials, international partners, and government representatives to mark what many described as a major step forward in protecting Caribbean lives.
The opening of this facility positions Saint Lucia not just as a beneficiary of improved health services, but as a regional hub for public health protection. Samples from across the Caribbean can now be securely transported to the Saint Lucia lab for advanced testing, with results returned swiftly to support patient care across member states.
During his keynote address the Minister for Health, Wellness and Nutrition, Hon. Moses Jn Baptiste, said the new facility goes beyond testing as it positions the region to get ahead of health threats before they become crises. “From emerging infectious diseases to environmental health threats, the challenges we face are increasingly complex and interconnected. Facilities such as this one ensure that we are not merely reacting to crises but proactively preparing for them. This expanded laboratory significantly enhances our diagnostic capabilities, strengthens surveillance systems and supports advanced testing and research, it empowers healthcare professionals with accurate and timely data. Data that informs strong and sound decision making and protects communities across our island and the wider Caribbean. This facility also symbolizes partnership. CARPHA has and continues to serve as a pillar of regional cooperation, uniting member states in the pursuit of stronger public health systems.”
The laboratory is equipped to carry out advanced testing to identify germs and bacteria and to determine which medicines can still effectively treat them. This type of testing is especially important in addressing the growing problem of antimicrobial resistance, which occurs when common medicines such as antibiotics stop working because the germs they are meant to fight have adapted and become resistant.
CARPHA’s Executive Director, Dr. Lisa Indar, says the expansion means faster results, better access, and stronger health security for every Caribbean nation. “By expanding testing capacities across geographically distributed labs, we are reducing turnaround times, from weeks to days and to hours, improving access to diagnostics closer to our countries and enabling early detection of our priority pathogens. This directly contributes to reducing disease spread and strengthening the Caribbean’s regional health security system. This integrated lab, capable of testing. Human. environmental, water and food samples alongside expanded microbiology and EMR capacity enhances the efficiency and the reliability of sample referral across our island states. It allows specimens to be transported, tested and analyzed with speed, greater speed and precision supporting more timely public health action.”
With three referral laboratories now in operation, CARPHA is better positioned to detect, monitor, and respond to resistant infections across Caribbean countries in a more efficient and timely manner. The expansion of the laboratory’s capabilities was made possible through funding from the Pandemic Fund and the UK Fleming Fund, international grants aimed at strengthening health systems and combatting drug-resistant infections worldwide.